JNJ-42226314
General
Type : Indole, Thiazole, Azetidin, Piperazine, Sulfur Compound
Chemical_Nomenclature : [1-(4-fluorophenyl)indol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone
Canonical SMILES : C1CN(CCN1C2CN(C2)C(=O)C3=CC4=C(C=C3)N(C=C4)C5=CC=C(C=C5)F)C(=O)C6=NC=CS6
InChI : InChI=1S\/C26H24FN5O2S\/c27-20-2-4-21(5-3-20)32-9-7-18-15-19(1-6-23(18)32)25(33)31-16-22(17-31)29-10-12-30(13-11-29)26(34)24-28-8-14-35-24\/h1-9,14-15,22H,10-13,16-17H2
InChIKey : IVOACCSOISMVBL-UHFFFAOYSA-N
Other name(s) : SCHEMBL698521 || CHEMBL3658400 || GTPL10661 || BDBM150300
MW : 489.6
Formula : C26H24FN5O2S
CAS_number : 1252765-13-1
PubChem : 59625954
UniChem : IVOACCSOISMVBL-UHFFFAOYSA-N
Target
Families : JNJ-42226314 ligand of proteins in family
Monoglyceridelipase_lysophospholip
Protein :
human-MGLL
References (1)
| Title : Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor - Wyatt_2020_J.Pharmacol.Exp.Ther_372_339 |
| Author(s) : Wyatt RM , Fraser I , Welty N , Lord B , Wennerholm M , Sutton S , Ameriks MK , Dugovic C , Yun S , White A , Nguyen L , Koudriakova T , Tian G , Suarez J , Szewczuk L , Bonnette W , Ahn K , Ghosh B , Flores CM , Connolly PJ , Zhu B , Macielag MJ , Brandt MR , Chevalier K , Zhang SP , Lovenberg T , Bonaventure P |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 372 :339 , 2020 |
| Abstract : |
| PubMedSearch : Wyatt_2020_J.Pharmacol.Exp.Ther_372_339 |
| PubMedID: 31818916 |